Ingrid Brown
Obstetrics & Gynecology · Round Rock, TXNPI 1700917580
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 43.2% of the total. Reporting peaked in 2022 at $339 and has fallen 52.8% since, to $160 in 2025.
Across 67 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$569
- Mayne Pharma Commercial LLC$256
- Astellas Pharma US Inc$138
- Hologic Sales And Service, LLC$97
- Avion Pharmaceuticals$45
- Lupin Inc.$29
- plus $183 from 11 others
Across 1 payment — averaging $27,290 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$27K
What the payments were for
- Food & beverage$1,29198%
- Education$121%
- Gifts$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $569 |
| Mayne Pharma Commercial LLC | 8 | $256 |
| Astellas Pharma US Inc | 7 | $138 |
| Hologic Sales And Service, LLC | 2 | $97 |
| Avion Pharmaceuticals | 3 | $45 |
| Lupin Inc. | 1 | $29 |
| Organon | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Millicent US Inc | 1 | $19 |
| Exeltis, USA Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Biogen | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Ascend Therapeutics US, LLC | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,316 in reported general payments places this provider in the 55th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 15 | $613 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Round Rock
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.